1life Healthcare (NASDAQ:ONEM) Given New $40.00 Price Target at Piper Sandler

1life Healthcare (NASDAQ:ONEM) had its price objective hoisted by Piper Sandler from $29.00 to $40.00 in a research note released on Tuesday, The Fly reports. Piper Sandler currently has an overweight rating on the stock.

A number of other research analysts also recently weighed in on ONEM. SunTrust Banks increased their price target on 1life Healthcare from $26.00 to $30.00 and gave the company a buy rating in a research note on Thursday, May 14th. Canaccord Genuity started coverage on 1life Healthcare in a research note on Friday, June 19th. They issued a buy rating and a $39.00 target price on the stock. Morgan Stanley boosted their target price on 1life Healthcare from $21.00 to $35.00 and gave the stock an overweight rating in a research report on Monday, May 18th. Citigroup lowered their price target on 1life Healthcare from $25.00 to $20.00 and set a neutral rating for the company in a research note on Wednesday, April 1st. Finally, Wells Fargo & Co lifted their price objective on shares of 1life Healthcare from $18.00 to $23.00 and gave the stock an equal weight rating in a research note on Thursday, May 14th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $30.56.

1life Healthcare stock opened at $36.32 on Tuesday. The firm has a market cap of $4.02 billion and a P/E ratio of -12.79. 1life Healthcare has a 1 year low of $15.00 and a 1 year high of $42.00. The company’s 50-day simple moving average is $32.83.

1life Healthcare (NASDAQ:ONEM) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.40) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.17) by ($0.23). The company had revenue of $78.76 million for the quarter, compared to analyst estimates of $74.79 million. On average, analysts forecast that 1life Healthcare will post -1.05 earnings per share for the current year.

Several institutional investors and hedge funds have recently modified their holdings of ONEM. Ameritas Investment Partners Inc. bought a new stake in 1life Healthcare during the 1st quarter worth approximately $30,000. Victory Capital Management Inc. acquired a new position in shares of 1life Healthcare in the first quarter valued at approximately $55,000. Lindbrook Capital LLC bought a new stake in shares of 1life Healthcare during the first quarter worth $73,000. Strs Ohio acquired a new stake in shares of 1life Healthcare during the first quarter worth $88,000. Finally, Citigroup Inc. bought a new stake in 1life Healthcare in the 1st quarter valued at $101,000. Institutional investors and hedge funds own 50.95% of the company’s stock.

About 1life Healthcare

1Life Healthcare, Inc operates a membership-based primary care platform. The company develops a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. It also provides medical services in-office and virtually. As of September 30, 2019, the company had approximately 397,000 members in 9 markets in the United States; 6,000 enterprise clients; and health network partnerships.

Recommended Story: How Does the Quiet Period Work?

The Fly

Analyst Recommendations for 1life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.